key: cord-1018971-b1ahtb5u authors: Odone, Anna; Delmonte, Davide; Gaetti, Giovanni; Signorelli, Carlo title: Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance date: 2020-11-30 journal: Public Health DOI: 10.1016/j.puhe.2020.11.016 sha: 924b19daf0efe9323906ca9c9d9543b910373c1f doc_id: 1018971 cord_uid: b1ahtb5u Objectives It important to quantify the true burden of coronavirus disease 2019 (COVID-19) in different countries, to enable informed decisions about imposing and relaxing control measures. COVID-19 surveillance data fails in this respect, as it is influenced by different definitions, control policies and capacities. This article aims to quantify excess mortality and estimate the distribution between COVID-19 and non-COVID-19 causes of death. Study design Observational study and mathematical modelling. Methods Publicly available data from multiple institutional sources were used and an in-depth analysis was carried out of deaths from all causes between 2015 and 2020 in Italy at the national, regional and local level. Excess mortality over time and space was first explored, followed by an assessment of how this related to COVID-19 surveillance and, ultimately, assuming a fixed male:female ratio, a model was developed and applied to estimate the proportions of COVID-19 and non-COVID-19 excess mortality in 2020. Results In Italy, the mortality rate doubled in March and April 2020 compared with data from 2015-2019 (+109%), with excess mortality reaching >600% in large municipalities in northern areas. Notified COVID-19 deaths accounted for only 43·5% (regional range: 43–62%) of excess mortality. It is estimated that more than two-thirds of excess deaths that were not captured by surveillance are non-COVID-19 deaths, which could be a result of the excess burden on the health systems, in addition to reduced demand and supply of other non-COVID healthcare services. Conclusions The impact of COVID-19 during the early stages of the pandemic is much larger than official figures have reported. Monitoring excess mortality helps to capture the full effect of the COVID-19 pandemic, which differs between regions in Italy. In addition, the COVID-19 pandemic has also resulted in significant indirect effects on the well-being of the population. The rapid spread of coronavirus disease 2019 (COVID- 19) has posed a challenge to governments that is unprecedented in the modern era. Given continued uncertainties about infection transmission and effective control measures, it is essential to have timely and accurate data on the burden of disease that the COVID-19 pandemic is generating. These data are needed to inform decisions about imposing and relaxing nonpharmaceutical countermeasures, such as restrictions on movement, and to facilitate learning from experiences of others, both internationally and within countries. It has been previously argued that countries are lacking a robust system of epidemiological intelligence to guide and inform public health action, and that current surveillance systems in most countries, including Italy, merely consist of counting COVID-19 cases and deaths with diverse criteria. 1 How deadly has COVID-19 been with respect to the population (in different areas)? How many people have been infected by the virus and how many are dying? The Italian National COVID-19 surveillance system does not enable such questions to be answered. It is known that data of notified COVID-19 deaths underestimates the true burden of COVID-19 as it does not include those who died but did not get tested for coronavirus infection. 2 In addition, the COVID-19 pandemic will have an indirect effect on mortality through different pathways, including health services running at stretched capacity, unmet demand for healthcare services other than and fear in the population to seek medical care. The World Health Organisation (WHO) has provided criteria for coding deaths due to COVID-19, yet there is considerable variation in reported COVID-19 mortality. Consequently, there is growing support for the use of excess all-cause mortality. This has the advantage of avoiding differences in diagnostic recording. It can also be expected to capture the full, both direct and indirect, effect of the COVID-19 pandemic. However, this measure will be most useful if there is also an understanding of how it relates to the narrower definitions of COVID-19 deaths reported in official figures. It is the responsibility of public health officials to quantify the real direct and indirect impact of the COVID-19 emergency on population health, and to explore its determinants related to the natural history of COVID-19, to its spread at the community level and to its management within and outside health services. In this context, the aim of the current study is to carry out an in-depth analysis of all-cause mortality rates in Italy between 2015 and 2020, at the national, regional and local level, and to compare these to COVID-19 surveillance mortality data. From these data, the current study estimates how much of the excess mortality that was not captured by surveillance is directly and indirectly due to COVID-19, thus deriving meaningful elements to quantify the true burden of the pandemic in Italy. J o u r n a l P r e -p r o o f Publicly available data were used from multiple institutional sources at the local, regional and national level. The number of deaths from all causes were retrieved from the Italian National Institute of Statistics (Istituto Nazionale di Statistica, ISTAT) for the period from 1st January 2015 to 15th April 2020. Mortality statistics were obtained from the National Resident Population Register (ANPR) and made available by ISTAT. 3 Data for the period from 1st January to 15th April 2020 have been released by ISTAT earlier than usual to support the development of responses to the COVID-19 pandemic. 3 There are 7900 municipalities in Italy, grouped into 170 provinces and 21 regions. Mortality data for the study period were available for 4433 municipalities, which corresponds to 57·2% of the total Italian population. Morality data were retrieved by month, gender and municipality. Population statistics were retrieved from the ISTAT demographic database to compute mortality rates. COVID-19 data were obtained from the national COVID-19 surveillance reporting system, established by the Italian Government on 24th February 2020 4 and managed by the National Institute of Health, and into which regional authorities are required to report daily disaggregated microbiological and epidemiological data. Aggregated COVID-19 surveillance data are published daily on a dedicated publicly available online dashboard. 5 For the current analysis, a COVID-19 death was defined according to the national COVID-19 surveillance reporting system as those occurring in patients testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using reverse transcription polymerase chain reaction (RT-PCR), regardless of the presence of pre-existing diseases that may have contributed to death. 6 The objective was to first quantify excess deaths, then compare them to COVID-19 surveillance A model was developed to estimate the excess mortality in 2020 in its different components: first, the increase in all-cause deaths in 2020 was calculated, compared to baseline, by sex in each region that (i) had ISTAT data available for at least 50% of the total population, (ii) had a total population >1 million, and (iii) had at least 700 notified COVID-19 deaths between 1st March and 15th April. The increase in absolute numbers of male and female deaths from all causes between baseline and 2020 (∆ and ∆ ) was rescaled for each region, and expressed as per equation 1 (eq. , representing the number of COVID-19 deaths reported by the national surveillance reporting system, , the number of COVID-19-deaths not captured by the national COVID-19 surveillance reporting system and , the number of excess deaths from other causes. From this, eq·2a and eq·2b were derived and, in turn, , was calculated from eq.1 (eq.3). Using data on the regional male:female distribution of deaths at baseline and in 2020, and assuming a fixed male:female distribution of COVID-19-related deaths ( ), the model allows an estimate to be calculated of the proportion of excess mortality attributable to COVID-19 and to non-COVID-19 causes that are associated with the pandemic. Data were analysed on 34·5 million Italian residents in 4433 municipalities. The Italy), the percentage increase was even greater, at +1117%, +990%, +973% and +723%, respectively, for these four municipalities, decreasing to +104%, +200%, +182% and +313%, respectively, in the first half of April (see Table S1 ). In total, 94·4% of the municipalities reporting over 400% increases in excess deaths were in the Lombardy region, and municipalities reporting ≥200% increase were in Lombardy (79·4%), Emilia-Romagna (12·7%), Piedmont (3·2%), Veneto, Marche and Trentino Alto-Adige (1·6 % each). The regional distribution of municipalities reporting >50% increases in excess deaths is reported in J o u r n a l P r e -p r o o f (Table 2 ). In all regions, the proportion of allcause excess deaths attributed to men at baseline ranged from 46·3% to 46·9%, with the exception of Liguria (45·2%), but increased to 48·1-52·6% in 2020 (+12·9% in Marche, +10·3% in Lombardy, +9·5% in Emilia Romagna, +6·2% in Piedmont, +5·5% in Liguria, +2·6% in the Veneto region, and +5·9% in the whole country, Table 3 ). The death count has doubled in Italy in March and April 2020 compared with the same months in 2015-2019. This is an unprecedented mortality burden increase. In particular, deaths for all causes increased in March 2020 by >600% in more than ten large municipalities in the north of Italy, with a peak increase of >1100%. However, with geographical variability, COVID-19 deaths notified through the Italian national COVID-19 surveillance system accounted for only 40% of the excess mortality. Within excess mortality that was not captured by COVID-19 surveillance, our model quantifies that more than two-thirds of excess deaths might be due to causes other than COVID-19. This study initially looked at excess mortality patterns over time and space, then combined and compared excess mortality data with COVID-19 official statistics, and ultimately modelled the different contribution of COVID-19 morbidity and non-COVID-19 clinical burden. Therefore, the current analysis not only allows quantification of the true population-level health impact of the COVID-19 emergency in Italy, but it also determines meaningful elements to describe and interpret the characteristics of the COVID-19 epidemic at the national and regional level, and enables comparisons with international settings. The current data do not support the hypothesis previously put forward 9-11 that COVID-19 was present in Italy and causing excess mortality earlier than reported by the national COVID- and does not vary across regions, it has been previously argued 1 that varying regional control strategies and capacities may have influenced COVID-19 death counts. While COVID-19 surveillance data across countries are not easily comparable because of different adopted classifications and case/death definitions, it is possible to compare excess mortality data. Although scholars have identified monitoring excess mortality (a consistent measurement of the COVID-19 pandemic scale across time and space) 14,15 as a priority, few comprehensive analyses of excess deaths in 2020 have been published to date. [15] [16] [17] [18] [19] With reference to Italy, several recent descriptive studies analysed excess morality in the small city of Nembro (heavily impacted by the COVID-19 outbreak), 20 and in selected major Italian cities, 11, 21, 22 but with no complete regionallevel analysis. Excess mortality data from other countries confirms that, in areas hit by the COVID-19 outbreak, death rates have risen above historical averages. 23 Another analysis conducted on 14 countries worldwide reported excess deaths to be highest in Spain (17,200 deaths estimate), followed by the UK and Italy. [26] [27] [28] In addition to assessing excess mortality and how it relates with COVID-19 official statistics, the second part of the current analysis estimated how excess deaths that were not captured by surveillance are distributed between additional COVID-19 deaths and deaths due to causes other than COVID-19; the results suggest a large proportion belong to non-COVID-19 related deaths. Although the outputs of the current study's model should be taken with caution, there is a strong rationale, and accumulating data from the literature, suggesting that the COVID-19 pandemic has indirectly increased mortality through different pathways, including decreased demand and supply of other non-COVID healthcare services. As health services were reorganised to manage COVID-19 patients at the hospital and community level (e.g. converting wards into dedicated COVID-19 wards, and postponing elective procedures, hospitalisations and other services), the healthcare needs of patients with chronic conditions may not have been met. In addition, fear of nosocomial SARS-CoV-2 transmission may have stopped individuals seeking care when in need, with reports from several countries showing decreased hospitalisations and emergency admissions. 23, 24, [29] [30] [31] [32] Recent data from a large multicentre Italian study showed hospital admissions for acute myocardial J o u r n a l P r e -p r o o f infarction (AMI) decreased by 48.4% compared with 2019, and AMI case fatality increased threefold during the COVID-19 pandemic. 26 In addition, data from another Italian study showed longer times from symptom onset to hospital admission in patients with myocardial infarction during the COVID-19 pandemic compared with previous years. 33 In the UK, attendances at emergency departments dropped by 30% in March 2020 compared with March 2019 27 and, in France, researchers reported a doubled incidence of out-of-hospital cardiac arrests and decreased survival rates. 34 In terms of other chronic diseases, including cancer, preliminary data suggest that the COVID-19 pandemic has resulted in delays in diagnosis, with possible detrimental effects on survival. 35 Although not conclusive, data from different settings suggest the negative indirect effects associated with the COVID-19 lockdown and healthcare service adjustments are accounting for a substantial proportion of the reported excess mortality. This is among one of the first studies to attempt to quantify the proportions of excess mortality, building the reasoning around the fact that reported COVID-19 deaths for the male:female ratio is different from the non-COVID-19 ratio. 36 If the true COVID-19 death male:female ratio is different to that reported in the official statistics 37 or if other factors have influenced the 2020 male:female mortality ratio, this could bias the current estimates. The current study has some additional limitations that need to be acknowledged. Data on deaths from the ISTAT do not cover the entire Italian population, thus generalisation of estimates to the whole country introduces some statistical fluctuations, which is further increased by regional heterogenicity in data coverage. However, there is nothing to suggest that trends in deaths are distributed differentially in municipalities that were included in ISTAT statistics compared with those that were not included. To account for uncomplete data coverage, the current study reports municipal-level data as a whole and only includes provincial and regional area estimates where data coverage is >50%. In addition, statistical fluctuations were minimised when the model was applied to the Italian national level. Another limitation is that age distribution of the study population was not considered or analysed into different age strata as this would have returned too few data to be imputed in the model; however, age was included in the analysis of a recent Italian report. 28 The current pandemic has caused an unprecedented health burden worldwide; after China, Italy was the first country to be heavily impacted by the COVID-19 outbreak. While it is important to wait several months to get more complete and comprehensive mortality data and to detect any harvesting effect, 28 the current study contributes to the accumulating body of knowledge, unmasking the true negative impact of COVID-19 on population health, and underlining how such impact might be J o u r n a l P r e -p r o o f associated with unmet non-COVID-19 medical needs. While raising awareness of the need to build and maintain a robust system of real-time intelligence of the epidemic, including rapid mortality surveillance, the current analysis will help inform the planning, implementation and monitoring of healthcare service delivery as the pandemic progresses, and offers effective guidance to public health action so that nobody, regardless of infection status, is left behind. J o u r n a l P r e -p r o o f Ethical approval Given the study design (observational study) and the sources of data (analysis of publicly available data), no ethical approval was required to conduct the study. This research received no specific grant from any funding agency in the public, commercial or notfor-profit sectors. a Data from the national COVID-19 surveillance reporting system, ISTAT. b Regions were selected with the following inclusion criteria: (i) total population >1 million; (ii) ISTAT available for at least 50% of total population; (iii) at least 700 COVID-19 notified deaths between 1st March and 15th April. c Rescaled to 100% population coverage. J o u r n a l P r e -p r o o f COVID-19 deaths in Lombardy, Italy: data in context. The Lancet Public Covid-19: Death rate in England and Wales reaches record high because of covid-19 Decessi e Cause di Morte. ISTAT; 2020 Presidency of the Council of Ministers. COVID-19 Italian Integrated surveillance The Civil Protection Department of the Italian Governament. COVID-19 National Surveillance Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy COVID-19 sex-disaggregated data tracker Italian scientists investigate possible earlier emergence of coronavirus SARS-COV-2 was already spreading in France in late Estimating the risk of sustained community transmission of COVID-19 outside Mainland China Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system Extensive Testing May Reduce COVID-19 Mortality: A Lesson From Northern Italy Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' COVID-19: a need for real-time monitoring of weekly excess deaths Rapid Estimation of Excess Mortality during the COVID-19 Pandemic in Portugal -Beyond Reported Deaths Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network Excess mortality in Brazil in times of Covid-19 Excess mortality due to COVID-19 in Germany Assessing the Impact of the Covid-19 Pandemic on US Mortality: A County-Level Analysis. medRxiv : the preprint server for health sciences Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy Estimating weekly excess mortality at subnational level in Italy during the COVID-19 pandemic Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy Letter: Back Pain and Accesses to Emergency Departments During COVID-19 Lockdown in Italy Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era What is happening to non-covid deaths? Impatto dell'Epidemia COVID-19 sulla mortalità totale della popolazione residente primo trimestre Children with Covid-19 in Pediatric Emergency Departments in Italy Changes in emergency service access after spread of COVID19 across Italy Delayed access or provision of care in Italy resulting from fear of COVID-19. The Lancet Child & Adolescent Health Collateral Effect of Covid-19 on Stroke Evaluation in the United States ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub a population-based, observational study. The Lancet Public Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease The gendered dimensions of COVID-19 Excess mortality in men and women in Massachusetts during the COVID-19 pandemic The authors declare no conflicts of interest. b Regions were selected with the following inclusion criteria: (i) total population >1 million; (ii) ISTAT available for at least 50% of total population; (iii) at least 700 COVID-19 notified deaths between 1st March and 15th April.